메뉴 건너뛰기
Thrombosis Research
Volumn 129, Issue 5, 2012, Pages 666-667
Monitoring unfractionated heparin with APTT: A French collaborative study comparing sensitivity to heparin of 15 APTT reagents
Author keywords

[No Author keywords available]
Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; HEPARIN; REAGENT;
EID: 84860489557     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.11.016     Document Type: Letter
Times cited : (21)
References (10)
  • 1
    • 0015514101 scopus 로고
    • A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time
    • D. Basu, A. Gallus, J. Hirsh, and J. Cade A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time N Engl J Med 287 1972 324 327
    • (1972) N Engl J Med , vol.287 , pp. 324-327
    • Basu, D.1    Gallus, A.2    Hirsh, J.3    Cade, J.4
  • 2
    • 0030057043 scopus 로고    scopus 로고
    • Wide variability in the sensitivity of APTT reagents for monitoring of heparin dosage
    • on behalf of the steering committee of the UK national quality assessment scheme for blood coagulation
    • S. Kitchen, I. Jennings, T.A.L. Woods on behalf of the steering committee of the UK national quality assessment scheme for blood coagulation Wide variability in the sensitivity of APTT reagents for monitoring of heparin dosage J Clin Pathol 49 1996 10 14
    • (1996) J Clin Pathol , vol.49 , pp. 10-14
    • Kitchen, S.1    Jennings, I.2    Woods, T.A.L.3
  • 3
    • 0030014877 scopus 로고    scopus 로고
    • The therapeutic range for heparin therapy: Relationship between six activated partial thromboplastin time reagents and two heparin assays
    • S. Kitchen, and F.E. Preston The therapeutic range for heparin therapy: relationship between six activated partial thromboplastin time reagents and two heparin assays Thromb Haemost 75 1996 734 739
    • (1996) Thromb Haemost , vol.75 , pp. 734-739
    • Kitchen, S.1    Preston, F.E.2
  • 4
    • 45949086068 scopus 로고    scopus 로고
    • Parenteral anticoagulants: American College of Chest Physycians Evidence-Based Clinical Practice Guidelines (8th edition)
    • J. Hirsh, K.A. Bauer, M.B. Donati, M. Gould, M.M. Samama, and J. Weitz Parenteral anticoagulants: American College of Chest Physycians Evidence-Based Clinical Practice Guidelines (8th edition) Chest 133 2008 141S 159S
    • (2008) Chest , vol.133
    • Hirsh, J.1    Bauer, K.A.2    Donati, M.B.3    Gould, M.4    Samama, M.M.5    Weitz, J.6
  • 5
    • 0031665270 scopus 로고    scopus 로고
    • College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: Laboratory monitoring of unfractionated heparin therapy
    • J.D. Olson, C.F. Arkin, J.T. Brand, M.T. Cunningham, A. Giles, and J.A. Koepke College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy Arch Lab Med 122 1998 782 798
    • (1998) Arch Lab Med , vol.122 , pp. 782-798
    • Olson, J.D.1    Arkin, C.F.2    Brand, J.T.3    Cunningham, M.T.4    Giles, A.5    Koepke, J.A.6
  • 6
    • 33644645358 scopus 로고    scopus 로고
    • Guidelines on the use and monitoring of heparin
    • British committee for standards in haematology
    • T. Baglin, T.W. Barrowcliffe, A. Cohen, M. Greaves British committee for standards in haematology Guidelines on the use and monitoring of heparin Br J Haematol 133 2006 19 34
    • (2006) Br J Haematol , vol.133 , pp. 19-34
    • Baglin, T.1    Barrowcliffe, T.W.2    Cohen, A.3    Greaves, M.4
  • 7
    • 0032433948 scopus 로고    scopus 로고
    • Evaluation of the activated partial thromboplastin time (APTT) sensitivity to heparin using five commercial reagents: Implications for therapeutic monitoring
    • F. Manazato, A. Mengoni, A. Grilenzoni, and G. Lippi Evaluation of the activated partial thromboplastin time (APTT) sensitivity to heparin using five commercial reagents: implications for therapeutic monitoring Clin Chem Lab Med 36 1998 975 980
    • (1998) Clin Chem Lab Med , vol.36 , pp. 975-980
    • Manazato, F.1    Mengoni, A.2    Grilenzoni, A.3    Lippi, G.4
  • 8
    • 79955062619 scopus 로고    scopus 로고
    • Interlaboratory variation in heparin monitoring: Lessons from the quality management program of Ontario coagulation surveys
    • A. Cuker, A. Raby, K.A. Moffat, G. Flynn, and M.A. Crowther Interlaboratory variation in heparin monitoring: lessons from the quality management program of Ontario coagulation surveys Thromb Haemost 104 2010 837 844
    • (2010) Thromb Haemost , vol.104 , pp. 837-844
    • Cuker, A.1    Raby, A.2    Moffat, K.A.3    Flynn, G.4    Crowther, M.A.5
  • 9
    • 0034537596 scopus 로고    scopus 로고
    • Problems in laboratory monitoring of heparin dosage
    • S. Kitchen Problems in laboratory monitoring of heparin dosage Brit J Haematol 111 2000 397
    • (2000) Brit J Haematol , vol.111 , pp. 397
    • Kitchen, S.1
  • 10
    • 57749172924 scopus 로고    scopus 로고
    • Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time
    • A. Cuker, B. Ptashkin, B.A. Konkle, S.W. Pipe, H.C. Whinna, and X.L. Zheng Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time J Thromb Haemost 7 2009 80 86
    • (2009) J Thromb Haemost , vol.7 , pp. 80-86
    • Cuker, A.1    Ptashkin, B.2    Konkle, B.A.3    Pipe, S.W.4    Whinna, H.C.5    Zheng, X.L.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.